---
document_datetime: 2025-11-23 09:10:22
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/doribax.html
document_name: doribax.html
version: success
processing_time: 0.1001238
conversion_datetime: 2025-12-25 01:03:00.763185
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Doribax

[RSS](/en/individual-human-medicine.xml/66868)

##### Withdrawn

This medicine's authorisation has been withdrawn

doripenem

Medicine

Human

Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)
- [News on Doribax](#news-on)
- [More information on Doribax](#more-information-on-doribax-1461)
- [More information on Doribax](#related-medicines)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 25 July 2008, the European Commission issued a marketing authorisation valid throughout the European Union for the medicinal product Doribax, which had been approved for the treatment of nosocomial pneumonia, complicated intra-abdominal infections and complicated urinary tract infections.

The marketing authorisation holder (MAH) responsible for Doribax was Janssen-Cilag International N.V.

On 31 July 2014, the European Commission issued a decision to withdraw the marketing authorisation for Doribax, following its receipt of a letter dated 6 July 2014 notifying the Commission of the MAH's decision to voluntarily withdraw the marketing authorisation for this product for commercial reasons.

Doribax was marketed in the following European countries: Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Greece, Hungary, Italy, Liechtenstein, Lithuania, Luxemburg, Netherlands, Norway, Poland, Portugal, Slovenia, Spain, Sweden and United Kingdom.

Pursuant to this decision, the European public assessment report for Doribax is updated to reflect that the marketing authorisation is no longer valid.

Doribax : EPAR - Summary for the public

Reference Number: EMA/450072/2012

English (EN) (224.28 KB - PDF)

**First published:** 31/07/2008

**Last updated:** 17/10/2014

[View](/en/documents/overview/doribax-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-127)

български (BG) (273.3 KB - PDF)

**First published:**

31/07/2008

**Last updated:**

17/10/2014

[View](/bg/documents/overview/doribax-epar-summary-public_bg.pdf)

español (ES) (198.09 KB - PDF)

**First published:**

31/07/2008

**Last updated:**

17/10/2014

[View](/es/documents/overview/doribax-epar-summary-public_es.pdf)

čeština (CS) (244.75 KB - PDF)

**First published:**

31/07/2008

**Last updated:**

17/10/2014

[View](/cs/documents/overview/doribax-epar-summary-public_cs.pdf)

dansk (DA) (200.38 KB - PDF)

**First published:**

31/07/2008

**Last updated:**

17/10/2014

[View](/da/documents/overview/doribax-epar-summary-public_da.pdf)

Deutsch (DE) (527.11 KB - PDF)

**First published:**

31/07/2008

**Last updated:**

17/10/2014

[View](/de/documents/overview/doribax-epar-summary-public_de.pdf)

eesti keel (ET) (196.98 KB - PDF)

**First published:**

31/07/2008

**Last updated:**

17/10/2014

[View](/et/documents/overview/doribax-epar-summary-public_et.pdf)

ελληνικά (EL) (279.89 KB - PDF)

**First published:**

31/07/2008

**Last updated:**

17/10/2014

[View](/el/documents/overview/doribax-epar-summary-public_el.pdf)

français (FR) (198.98 KB - PDF)

**First published:**

31/07/2008

**Last updated:**

17/10/2014

[View](/fr/documents/overview/doribax-epar-summary-public_fr.pdf)

italiano (IT) (201.12 KB - PDF)

**First published:**

31/07/2008

**Last updated:**

17/10/2014

[View](/it/documents/overview/doribax-epar-summary-public_it.pdf)

latviešu valoda (LV) (262.52 KB - PDF)

**First published:**

31/07/2008

**Last updated:**

17/10/2014

[View](/lv/documents/overview/doribax-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (227.64 KB - PDF)

**First published:**

31/07/2008

**Last updated:**

17/10/2014

[View](/lt/documents/overview/doribax-epar-summary-public_lt.pdf)

magyar (HU) (239.7 KB - PDF)

**First published:**

31/07/2008

**Last updated:**

17/10/2014

[View](/hu/documents/overview/doribax-epar-summary-public_hu.pdf)

Malti (MT) (304.78 KB - PDF)

**First published:**

31/07/2008

**Last updated:**

17/10/2014

[View](/mt/documents/overview/doribax-epar-summary-public_mt.pdf)

Nederlands (NL) (206.99 KB - PDF)

**First published:**

31/07/2008

**Last updated:**

17/10/2014

[View](/nl/documents/overview/doribax-epar-summary-public_nl.pdf)

polski (PL) (245.25 KB - PDF)

**First published:**

31/07/2008

**Last updated:**

17/10/2014

[View](/pl/documents/overview/doribax-epar-summary-public_pl.pdf)

português (PT) (197.43 KB - PDF)

**First published:**

31/07/2008

**Last updated:**

17/10/2014

[View](/pt/documents/overview/doribax-epar-summary-public_pt.pdf)

română (RO) (225.76 KB - PDF)

**First published:**

31/07/2008

**Last updated:**

17/10/2014

[View](/ro/documents/overview/doribax-epar-summary-public_ro.pdf)

slovenčina (SK) (242.5 KB - PDF)

**First published:**

31/07/2008

**Last updated:**

17/10/2014

[View](/sk/documents/overview/doribax-epar-summary-public_sk.pdf)

slovenščina (SL) (239.02 KB - PDF)

**First published:**

31/07/2008

**Last updated:**

17/10/2014

[View](/sl/documents/overview/doribax-epar-summary-public_sl.pdf)

Suomi (FI) (199.76 KB - PDF)

**First published:**

31/07/2008

**Last updated:**

17/10/2014

[View](/fi/documents/overview/doribax-epar-summary-public_fi.pdf)

svenska (SV) (198.13 KB - PDF)

**First published:**

31/07/2008

**Last updated:**

17/10/2014

[View](/sv/documents/overview/doribax-epar-summary-public_sv.pdf)

## Product information

Doribax : EPAR - Product Information

English (EN) (611.03 KB - PDF)

**First published:** 02/12/2009

**Last updated:** 17/10/2014

[View](/en/documents/product-information/doribax-epar-product-information_en.pdf)

[Other languages (23)](#file-language-dropdown-60)

български (BG) (1.2 MB - PDF)

**First published:**

02/12/2009

**Last updated:**

17/10/2014

[View](/bg/documents/product-information/doribax-epar-product-information_bg.pdf)

español (ES) (623.54 KB - PDF)

**First published:**

02/12/2009

**Last updated:**

17/10/2014

[View](/es/documents/product-information/doribax-epar-product-information_es.pdf)

čeština (CS) (912.08 KB - PDF)

**First published:**

02/12/2009

**Last updated:**

17/10/2014

[View](/cs/documents/product-information/doribax-epar-product-information_cs.pdf)

dansk (DA) (621.69 KB - PDF)

**First published:**

02/12/2009

**Last updated:**

17/10/2014

[View](/da/documents/product-information/doribax-epar-product-information_da.pdf)

Deutsch (DE) (663.11 KB - PDF)

**First published:**

02/12/2009

**Last updated:**

17/10/2014

[View](/de/documents/product-information/doribax-epar-product-information_de.pdf)

eesti keel (ET) (615.67 KB - PDF)

**First published:**

02/12/2009

**Last updated:**

17/10/2014

[View](/et/documents/product-information/doribax-epar-product-information_et.pdf)

ελληνικά (EL) (1.27 MB - PDF)

**First published:**

02/12/2009

**Last updated:**

17/10/2014

[View](/el/documents/product-information/doribax-epar-product-information_el.pdf)

français (FR) (665.57 KB - PDF)

**First published:**

02/12/2009

**Last updated:**

17/10/2014

[View](/fr/documents/product-information/doribax-epar-product-information_fr.pdf)

íslenska (IS) (636.63 KB - PDF)

**First published:**

02/12/2009

**Last updated:**

17/10/2014

[View](/is/documents/product-information/doribax-epar-product-information_is.pdf)

italiano (IT) (630.54 KB - PDF)

**First published:**

02/12/2009

**Last updated:**

17/10/2014

[View](/it/documents/product-information/doribax-epar-product-information_it.pdf)

latviešu valoda (LV) (623 KB - PDF)

**First published:**

02/12/2009

**Last updated:**

17/10/2014

[View](/lv/documents/product-information/doribax-epar-product-information_lv.pdf)

lietuvių kalba (LT) (969.05 KB - PDF)

**First published:**

02/12/2009

**Last updated:**

17/10/2014

[View](/lt/documents/product-information/doribax-epar-product-information_lt.pdf)

magyar (HU) (928.55 KB - PDF)

**First published:**

02/12/2009

**Last updated:**

17/10/2014

[View](/hu/documents/product-information/doribax-epar-product-information_hu.pdf)

Malti (MT) (1000.9 KB - PDF)

**First published:**

02/12/2009

**Last updated:**

17/10/2014

[View](/mt/documents/product-information/doribax-epar-product-information_mt.pdf)

Nederlands (NL) (646.66 KB - PDF)

**First published:**

02/12/2009

**Last updated:**

17/10/2014

[View](/nl/documents/product-information/doribax-epar-product-information_nl.pdf)

norsk (NO) (614.39 KB - PDF)

**First published:**

02/12/2009

**Last updated:**

17/10/2014

[View](/no/documents/product-information/doribax-epar-product-information_no.pdf)

polski (PL) (918.2 KB - PDF)

**First published:**

02/12/2009

**Last updated:**

17/10/2014

[View](/pl/documents/product-information/doribax-epar-product-information_pl.pdf)

português (PT) (629.03 KB - PDF)

**First published:**

02/12/2009

**Last updated:**

17/10/2014

[View](/pt/documents/product-information/doribax-epar-product-information_pt.pdf)

română (RO) (643.89 KB - PDF)

**First published:**

02/12/2009

**Last updated:**

17/10/2014

[View](/ro/documents/product-information/doribax-epar-product-information_ro.pdf)

slovenčina (SK) (933.18 KB - PDF)

**First published:**

02/12/2009

**Last updated:**

17/10/2014

[View](/sk/documents/product-information/doribax-epar-product-information_sk.pdf)

slovenščina (SL) (906.43 KB - PDF)

**First published:**

02/12/2009

**Last updated:**

17/10/2014

[View](/sl/documents/product-information/doribax-epar-product-information_sl.pdf)

Suomi (FI) (624.18 KB - PDF)

**First published:**

02/12/2009

**Last updated:**

17/10/2014

[View](/fi/documents/product-information/doribax-epar-product-information_fi.pdf)

svenska (SV) (894.65 KB - PDF)

**First published:**

02/12/2009

**Last updated:**

17/10/2014

[View](/sv/documents/product-information/doribax-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** II/0022 21/02/2012

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

## Product details

Name of medicine Doribax Active substance doripenem International non-proprietary name (INN) or common name doripenem Therapeutic area (MeSH)

- Pneumonia, Ventilator-Associated
- Pneumonia, Bacterial
- Urinary Tract Infections
- Bacterial Infections
- Cross Infection

Anatomical therapeutic chemical (ATC) code J01DH04

### Pharmacotherapeutic group

Antibacterials for systemic use

### Therapeutic indication

Doribax is indicated for the treatment of the following infections in adults:

- nosocomial pneumonia (including ventilator-associated pneumonia);
- complicated intra-abdominal infections;
- complicated urinary tract infections.

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

## Authorisation details

EMA product number EMEA/H/C/000891 Marketing authorisation holder

Janssen-Cilag International NV

Turnhoutseweg, 30

Marketing authorisation issued 25/07/2008 Withdrawal of marketing authorisation 31/07/2014 Revision 10

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Doribax : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (287.25 KB - PDF)

**First published:** 02/12/2009

**Last updated:** 17/10/2014

[View](/en/documents/procedural-steps-after/doribax-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

Doribax-H-C-P46-32 : EPAR - Assessment Report

Adopted

Reference Number: EMA/594076/2014

English (EN) (465.01 KB - PDF)

**First published:** 17/10/2014

**Last updated:** 17/10/2014

[View](/en/documents/variation-report/doribax-h-c-p46-32-epar-assessment-report_en.pdf)

Doribax-H-C-891-P46-26 : EPAR - Assessment Report

Adopted

Reference Number: EMEA/594075/2014

English (EN) (615.64 KB - PDF)

**First published:** 17/10/2014

**Last updated:** 17/10/2014

[View](/en/documents/variation-report/doribax-h-c-891-p46-26-epar-assessment-report_en.pdf)

Doribax-H-C-891-P46-31 : EPAR - Assessment Report

Adopted

English (EN) (1023.51 KB - PDF)

**First published:** 17/10/2014

**Last updated:** 17/10/2014

[View](/en/documents/variation-report/doribax-h-c-891-p46-31-epar-assessment-report_en.pdf)

Doribax-H-C-891-P46-26.1 : EPAR - Assessment Report

Adopted

Reference Number: EMA/594074/2014

English (EN) (296.04 KB - PDF)

**First published:** 17/10/2014

**Last updated:** 17/10/2014

[View](/en/documents/variation-report/doribax-h-c-891-p46-261-epar-assessment-report_en.pdf)

Doribax-H-C-891-P46-30 : EPAR - Assessment Report

Adopted

Reference Number: EMA/594074/2014

English (EN) (1.17 MB - PDF)

**First published:** 17/10/2014

**Last updated:** 17/10/2014

[View](/en/documents/variation-report/doribax-h-c-891-p46-30-epar-assessment-report_en.pdf)

Doribax-H-C-891-P46-25 : EPAR - Assessment Report

Adopted

Reference Number: EMA/CHMP/193555/2013

English (EN) (532.52 KB - PDF)

**First published:** 27/03/2013

**Last updated:** 17/10/2014

[View](/en/documents/variation-report/doribax-h-c-891-p46-25-epar-assessment-report_en.pdf)

Doribax-H-C-891-P46-24 : EPAR - Assessment Report

Adopted

Reference Number: EMA/CHMP/193555/2013

English (EN) (451.02 KB - PDF)

**First published:** 27/03/2013

**Last updated:** 17/10/2014

[View](/en/documents/variation-report/doribax-h-c-891-p46-24-epar-assessment-report_en.pdf)

Doribax-H-C-891-A20-45 : EPAR - Assessment Report - Article 20

Adopted

Reference Number: EMA/549030/2012

English (EN) (392.94 KB - PDF)

**First published:** 19/12/2012

**Last updated:** 17/10/2014

[View](/en/documents/variation-report/doribax-h-c-891-a20-45-epar-assessment-report-article-20_en.pdf)

## Initial marketing authorisation documents

Doribax : EPAR - Public assessment report

English (EN) (641.47 KB - PDF)

**First published:** 01/08/2008

**Last updated:** 17/10/2014

[View](/en/documents/assessment-report/doribax-epar-public-assessment-report_en.pdf)

Committee for medicinal products for human use summary of positive opinion for Doribax

Reference Number: EMEA/CHMP/185915/2008

English (EN) (202.7 KB - PDF)

**First published:** 30/05/2008

**Last updated:** 17/10/2014

[View](/en/documents/smop-initial/committee-medicinal-products-human-use-summary-positive-opinion-doribax_en.pdf)

#### News on Doribax

[Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 June 2012](/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-18-21-june-2012) 22/06/2012

[European Medicines Agency advises doctors treating patients with nosocomial pneumonia with Doribax](/en/news/european-medicines-agency-advises-doctors-treating-patients-nosocomial-pneumonia-doribax) 22/06/2012

#### More information on Doribax

Questions and answers on the review of Doribax (doripenem)

Reference Number: EMA/CHMP/411815/2012

English (EN) (295.12 KB - PDF)

**First published:** 22/06/2012

**Last updated:** 17/10/2014

[View](/en/documents/medicine-qa/questions-and-answers-review-doribax-doripenem_en.pdf)

Doribax: Product information as approved by the CHMP on 21 June 2012, pending endorsement by the European Commission

Adopted

English (EN) (629.85 KB - PDF)

**First published:** 22/06/2012

**Last updated:** 17/10/2014

[View](/en/documents/other/doribax-product-information-approved-chmp-21-june-2012-pending-endorsement-european-commission_en.pdf)

#### More information on Doribax

- [EMEA-000015-PIP01-07-M04 - paediatric investigation plan](/en/medicines/human/paediatric-investigation-plans/emea-000015-pip01-07-m04)

**This page was last updated on** 17/10/2014

## Share this page

[Back to top](#main-content)